Aptevo Therapeutics Inc. 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-221661
- Form type
- 10-Q
- CIK
- 0001671584
- Primary document
- https://www.sec.gov/Archives/edgar/data/1671584/000119312526221661/apvo-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aptevo Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-6.8M | - | - |
| Net Income | $-6.7M | - | - |
| Eps Basic | -6.41 | - | - |
| Eps Diluted | -6.41 | - | - |
| Cash And Equivalents | $14.5M | - | - |
| Total Assets | $19.9M | - | - |
| Total Liabilities | $8.3M | - | - |
| Shareholders Equity | $11.6M | - | - |
| Operating Cash Flow | $-8.0M | - | - |